Health & Research Goals
TB-500 (Thymosin Beta-4 Synthetic Fragment)
TB-500 (Fragmento Sintético de Timosina Beta-4)
TB-500 is a synthetic analogue of Thymosin Beta-4 (TB4), specifically the active fragment Ac-SDKPDMAEIEKFDKSKLKKTE-NH2 (amino acid…
Primary Description
TB-500 is a synthetic analogue of Thymosin Beta-4 (TB4), specifically the active fragment Ac-SDKPDMAEIEKFDKSKLKKTE-NH2 (amino acids 17–23 region, particularly the LKKTETQ actin-binding motif). Thymosin Beta-4 is a 43-amino acid protein naturally present in virtually all nucleated human cells, with the highest concentrations in platelets, white blood cells, and wound fluid. It plays a critical role in G-actin sequestration, cell migration, angiogenesis, wound healing, and tissue repair. TB-500 was popularized in the performance community after being identified as the active peptide responsible for TB4's wound-healing and recovery-promoting properties. It accelerates recovery from soft tissue injuries including muscle tears, tendon injuries, ligament damage, and skin wounds. It is widely used by athletes, fitness enthusiasts, and anti-aging practitioners.
Key Benefits
- Tissue repair
- Reduced inflammation
- Improved flexibility
Store lyophilized powder at 2–8°C; stable for 12–24 months. Reconstituted solution: refrigerate at 2–8°C and use within 30 days. Do not freeze reconstituted solution. Protect from light and heat.
Demonstrated Effects
- Accelerates healing of muscle tears, strains, and soft tissue injuries
- Promotes tendon and ligament repair and remodeling
- Stimulates angiogenesis (new blood vessel formation) for enhanced tissue perfusion
- Promotes keratinocyte migration for wound closure
- Anti-inflammatory effects in injured tissue
- Reduces scar tissue formation and promotes organized collagen deposition
- Improves flexibility and range of motion post-injury
- Neuroprotective and neuroregenerative effects (investigated for CNS injury)
- Cardiac protection in ischemia models — activates dormant cardiomyocyte progenitors
- Promotes hair follicle stem cell activation (hair growth potential)
Proposed Mechanisms of Action
1. G-Actin Sequestration and Cell Migration
The LKKTETQ motif in TB-500 binds G-actin (monomeric actin), preventing polymerization into F-actin. This actin-sequestering activity promotes cell motility — enabling keratinocytes, fibroblasts, and endothelial cells to migrate into wound sites for repair.
2. Angiogenesis Promotion
TB-500 promotes endothelial cell migration and tube formation, stimulating new blood vessel formation (angiogenesis) in injured tissue. Improved vascularization enhances oxygen and nutrient delivery for tissue repair.
3. Anti-inflammatory Effects
Downregulates inflammatory cytokines (IL-1beta, IL-6, TNF-alpha) at the injury site while promoting resolution of inflammation — creating the optimal environment for tissue repair without excessive inflammatory damage.
4. Integrin-Linked Kinase (ILK) Activation
TB-500 activates ILK signaling, promoting cell survival, migration, and differentiation of progenitor cells in cardiac and other tissues. This is particularly relevant for cardiomyocyte protection and cardiac repair.
5. Collagen Remodeling
Promotes organized collagen deposition and maturation during tissue repair, improving the structural quality of healed tissue and reducing disorganized scar formation.
Research Evidence & Clinical Data
Investigated Applications
Soft Tissue Injury Recovery
Anecdotal: HighTB-500's primary use in the performance and wellness community is accelerating recovery from muscle tears, tendon injuries, and ligament sprains. Users report significantly reduced healing time and improved quality of tissue repair. It is particularly valued for chronic or refractory injuries that have been slow to heal with conventional treatment.
Preclinical basis: Goldstein AL et al. (2012): TB4 promotes cell migration, angiogenesis, and anti-inflammatory effects via LKKTETQ motif. Multiple animal studies show accelerated wound healing and tendon repair.
Athletic Performance and Recovery
Anecdotal: HighBeyond injury treatment, many athletes use TB-500 proactively for enhanced training recovery, reduced DOMS (delayed onset muscle soreness), and improved tissue resilience. The angiogenic and anti-inflammatory effects support faster recovery between intense training sessions.
Preclinical basis: Enhanced angiogenesis from TB-500 improves tissue perfusion and oxygen delivery — beneficial for both recovery and ongoing training adaptation.
Cardiac Repair and Neuroprotection
Anecdotal: LowPreclinical research has demonstrated that Thymosin Beta-4 activates dormant cardiac stem cells, promotes cardiomyocyte survival post-MI, and supports neural repair after CNS injury. These applications are investigational and not established in human clinical practice.
Preclinical basis: Tseng AS et al. (2006): TB4 activates epicardial progenitors post-myocardial infarction. Bock-Marquette I et al. (2004): TB4 activates ILK and promotes cardiomyocyte survival.
Hair Growth
Anecdotal: EmergingThymosin Beta-4 activates hair follicle progenitor cells and has been investigated as a potential treatment for hair loss. Community reports of subcutaneous and intradermal injection near scalp for hair regrowth are emerging.
Preclinical basis: Philp D et al. (2004): TB4 accelerates hair growth in animal models via activation of hair follicle stem cells.
Scientific References
- 1.
- 2.Progress on the Function and Application of Thymosin β4Front Endocrinol (Lausanne)2021
- 3.
- 4.
- 5.Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applicationsExpert Opin Biol Ther2012
Safety Profile
Common Side Effects
- Injection site reactions (mild redness, bruising)
- Transient fatigue after injection (occasional)
- Mild nausea (rare)
- Headache (infrequent)
- Injection site reactions
- Fatigue (rare)
Contraindications
- Active malignancy (theoretical concern — angiogenesis promotion may support tumor growth)
- Pregnancy and breastfeeding (insufficient data)
- Children (insufficient safety data)
- Hypersensitivity to any component
- Active cancer
- Bleeding disorders
Legal & Regulatory Status
Not FDA-approved as a therapeutic drug. Thymosin Beta-4 is a research compound widely distributed through peptide vendors. Prohibited by WADA for use in competitive sports. Not a scheduled controlled substance. Compounded thymosin beta-4 preparations are available through some compounding pharmacies.
No aprobado por la FDA como medicamento terapéutico. Thymosin Beta-4 es un compuesto de investigación ampliamente distribuido a través de proveedores de péptidos. Prohibido por la WADA para su uso en deportes competitivos. No es una sustancia controlada clasificada. Las preparaciones compuestas de thymosin beta-4 están disponibles a través de algunas farmacias de compounding.
Research Protocols
Dosing Protocols
Routes of Administration
subcutaneous
intramuscular
Reconstitution Guide
Pharmacokinetics
| Half-Life | Plasma half-life approximately 30–60 minutes. However, tissue-level effects on cell migration and angiogenesis persist significantly longer. Systemic distribution throughout the body makes subcutaneous injection effective for both systemic and remote injury treatment. |
Monitoring & Risk Management
Ongoing Monitoring Steps
- Track injury healing progress with clinical assessment or imaging
- Monitor injection site tolerance
- Assess for any unusual tissue proliferation
- Re-evaluate at 4 weeks and 8 weeks of loading protocol
Critical Warning Signs
- Worsening pain or swelling at injury site
- Unusual growths or tissue changes
- Severe allergic reaction
- Persistent systemic fatigue or malaise
Featured in Stacking Protocols
Community-researched combinations involving this compound